IP Library Granted Patent US 12,503,711
Granted Patent B2
US 12,503,711 · App. 18/321,585 · Granted Dec 23, 2025

Method of producing and processing diamines to a diamine free base using a carbonate intermediate and an engineered microorganism

Inventors: Lauri H. Suominen (San Diego, CA); Connor J. Galleher (San Diego, CA); Michael Japs (San Diego, CA); Mark J. Burk (San Diego, CA); Cara Tracewell (San Diego, CA)
Assignee: Genomatica, Inc.
C12P13/001C12N1/02C12N1/20C12N9/88C12N9/96C12N11/16C12N15/52C12Y402/01001
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,503,711
App. No.
18/321,585
Granted
Dec 23, 2025
Kind
B2
Abstract

Provided is a method of producing and isolating a diamine produced by microbial fermentation that minimizes undesirable salt formation to provide a lower cost process.

Claims (31)

1 . A method for diamine (DA) production comprising steps of:

a) culturing a genetically engineered microorganism in a medium under suitable conditions and for a sufficient period of time form a cultured medium comprising one or more of DA carbonate, DA bicarbonate, or DA bis-bicarbonate, and/or DA carbamate or DA biscarbamate, wherein carbon dioxide, carbonate, bicarbonate or carbonic acid predominantly control pH of the medium, the microorganism comprising at least one exogenous nucleic acid encoding at least one enzyme of a DA synthesis pathway, and wherein the diamine comprises C 2 to C 7 methylene segments or C2 to C12 methylene segments;

b) converting at least one or more of the DA carbonate, DA bicarbonate, or DA bis-bicarbonate, and/or DA carbamate or DA biscarbamate, into DA free base and carbon dioxide; and;

c) isolating the DA free base;

wherein the DA synthesis pathway is a hexamethylenediamine synthesis pathway, a cadaverine synthesis pathway, a putrescine synthesis pathway, an ethylenediamine synthesis pathway, or a heptamethylenediamine synthesis pathway; and

wherein the at least one exogenous nucleic acid encoding at least one enzyme of a DA synthesis pathway comprises an exogenous nucleic acid encoding 3-oxoadipyl-CoA thiolase, 6-ACA transaminase or dehydrogenase, 6-aminocaproyl-CoA reductase, 6-ACA reductase, adipyl-CoA reductase, adipate reductase, 6-hydroxy 3-oxohexanoyl-CoA dehydrogenase, 2-aminopimelate decarboxylase, or homolysine decarboxylase, or combinations thereof.

2 . The method of claim 1 wherein the diamine comprises C 2 to C 7 methylene segments.

3 . The method of claim 2 wherein the diamine comprises C 4 to C 7 methylene segments.

4 . The method of claim 2 the diamine is hexamethylenediamine (HMD), cadaverine, putrescine, ethylenediamine, or heptamethylenediamine.

5 . The method of claim 1 wherein at least 50%, at least 60%, at least 70%, at least 80%, at least 90%, or at least 99.9% of the diamine in the medium comprises the one or more DA carbonate, DA bicarbonate, or DA bis-bicarbonate, and/or DA carbamate or DA biscarbamate.

6 . The method of claim 1 wherein the genetically engineered microorganism further comprises an exogenous nucleic acid encoding a carbonic anhydrase and forms one or more of carbon dioxide, carbonate, bicarbonate or carbonic acid, optionally comprising stoichiometric carbon dioxide from diamine production, respiration carbon dioxide, or by-product carbon dioxide.

7 . The method of claim 6 wherein the by-product carbon dioxide is associated with the formation of a by-product that is acetate, ethanol, succinate, 3-oxoadipate, or 3-hydroxyadipate.

8 . The method of claim 1 wherein one or more of carbon dioxide, carbonate, bicarbonate or carbonic acid is externally added to the medium.

9 . The method of claim 1 comprising HMD carbonate, HMD bicarbonate, HMD bis-bicarbonate, HMD carbamate, or HMD biscarbamate.

10 . The method of claim 1 wherein the genetically engineered microorganism forms carbon dioxide and DA at a molar ratio in the range of about 0.05:1 to about 7:1, respectively.

11 . The method of claim 1 wherein the cultured medium has a pH of about 6 to 9.5.

12 . The method of claim 1 wherein a carbonic anhydrase is present in sufficient amount to (a) enhance the formation of DA carbonate, DA bicarbonate, or DA bis-bicarbonate, and/or DA carbamate or DA biscarbamate by converting carbon dioxide to a bicarbonate and/or carbonate ions, (b) enhance the release of carbon dioxide from a solution of DA carbonate, DA bicarbonate, or DA bis-bicarbonate, and/or DA carbamate or DA biscarbamate by converting a bicarbonate and/or carbonate ions to carbon dioxide, or (c) both (a) and (b).

13 . The method of claim 1 comprising a carbonic anhydrase, wherein the carbonic anhydrase is provided by a second genetically engineered microorganism in the fermentation broth, said second genetically engineered microorganism comprising an exogenous nucleic acid encoding a carbonic anhydrase, or the carbonic anhydrase is provided by the genetically engineered microorganism that produces the DA and which comprises an exogenous nucleic acid encoding a carbonic anhydrase, optionally excreted to the broth, and optionally present in the microorganism's periplasm.

14 . The method of claim 13 wherein the carbonic anhydrase is from Desulfovibrio vulgaris.

15 . The method of claim 13 wherein the carbonic anhydrase is from Desulfovibrio vulgaris str “Miyazaki F” and comprises the amino acid sequence of SEQ ID NO: 1, which has been codon-optimized for expression in E. coli and is cloned into an expression vector under the control of a constitutive promoter, the amino acid sequence having an amino acid substitution to stabilize the carbonic anhydrase activity at elevated temperatures and alkaline pH and has one or more substitutions identified as: A56S, T30R, A40L, A84Q, G120R, T139M, K37R, E68AQ, A95V, Q119M, N145WFC, N213E, A219T, R31P, Q43M, V70I, H124T, H148T, V157A, M170F, H44L, M129F, S144R, Y49F, S126N, D196S, P136R, P174E, D195A, G89A, D96E, V100T, A121Q, A181K, M207A, S216D, wherein said one or more substitutions enhance stability, thermal stability, alkaline pH stability, or increased activity of the carbonic anhydrase.

16 . The method of claim 13 wherein the carbonic anhydrase is encoded by E. coli cynT (EcoCyc EG10176) or E. coli can (EcoCyc EG12319).

17 . A method for diamine (DA) production comprising the steps of:

a) culturing a genetically engineered microorganism in a medium under suitable conditions and for a sufficient period of time to form a cultured medium comprising one or more of DA carbonate, DA bicarbonate, DA bis-bicarbonate, DA carbamate or DA biscarbamate, wherein the diamine comprises C 2 to C 7 methylene segments or C2 to C12 methylene segments, and wherein the microorganism comprises at least one exogenous nucleic acid encoding at least one enzyme of a DA synthesis pathway, wherein percent dissolved inorganic carbon (DIC) in the medium is greater than or equal to 40%; and the DIC is determined by the formula:

DIC/TDCA×100

wherein TDCA is the Total Dissolved Counter Anions and is the sum of DIC and other anions,

b) converting the DA carbonate, DA bicarbonate, DA bis-bicarbonate, DA carbamate or DA biscarbamate into DA free base and carbon dioxide; and

c) isolating the DA free base.

18 . A method for diamine (DA) production comprising the steps of:

a) culturing a genetically engineered microorganism in a medium under suitable conditions and for a sufficient period of time to form a cultured medium comprising one or more of DA carbonate, DA bicarbonate, DA bis-bicarbonate (DA Carbonates) and/or DA carbamate or DA biscarbamate (DA Carbamates) in the medium, wherein at least 40% of diamine species in the medium comprises one or more of DA carbonate, DA bicarbonate, DA bis-bicarbonate, DA carbamate or DA biscarbamate, and wherein the microorganism comprises at least one exogenous nucleic acid encoding at least one enzyme of a DA synthesis pathway, and wherein the diamine comprises C2 to C7 methylene segments or C2 to C12 methylene segments;

b) converting the DA Carbonates and/or DA Carbamates into DA free base and carbon dioxide; and

c) isolating the DA free base.

Assignments (4)
SECURITY INTEREST Recorded Feb 10, 2026
From: GENOMATICA, INC.
To: AGAIN BIO APS
Reel/Frame 074708/0001 →
SECURITY INTEREST Recorded Dec 9, 2025
From: GENOMATICA, INC.
To: NOVO HOLDINGS A/S, AS COLLATERAL AGENT
Reel/Frame 073915/0027 →
SECURITY INTEREST Recorded Jun 2, 2025
From: GENOMATICA, INC.
To: OXFORD FINANCE LLC
Reel/Frame 071471/0770 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2023
From: SUOMINEN, LAURI H.; GALLEHER, CONNOR J.; JAPS, MICHAEL; BURK, MARK J.; TRACEWELL, CARA
To: GENOMATICA, INC.
Reel/Frame 063720/0735 →
Continuity (6)
Continuation 16927396 · Jul 13, 2020
Continuation 15538448
Provisional Application 62211315 · Aug 28, 2015
Provisional Application 62193693 · Jul 17, 2015
Provisional Application 62096309 · Dec 23, 2014
Related Publication 20240182935A1 · Jun 6, 2024
References Cited (18)
US 8509617B2 · Cao · 2013 [cited by applicant]
US 9458480B2 · Burk et al. · 2016 [cited by applicant]
US 10711289B2 · Suominen · 2020 [cited by examiner]
US 11702682B2 · Suominen · 2023 [cited by examiner]
US 20090246838A1 · Zelder · 2009 [cited by examiner]
US 20120282661A1 · Burk et al. · 2012 [cited by applicant]
CN 102056889A · 2011 [cited by applicant]
JP 2004222569A · 2004 [cited by applicant]
JP 2010275516A · 2010 [cited by applicant]
WO 2007113127A1 · 2007 [cited by applicant]
WO 2009092793A2 · 2009 [cited by applicant]
WO 2012114256A1 · 2012 [cited by applicant]
WO 2015152541A1 · 2015 [cited by applicant]
Prather, et al. (Oct. 2008) “De novo biosynthetic pathways: rational design of microbial chemical factories”, Current Opinion in Biotechnology, 19(5):468-474. [cited by applicant]
Bover-Cid, et al. (1999) “Improved screening procedure for biogenic amine production by lactic acid bacteria”, International Journal of Food Microbiology, 53:33-41. [cited by applicant]
Jo, et al. (Aug. 23, 2013) “Engineered [cited by applicant]
Kizer, et al. (May 2008) “Application of functional genomics to pathway optimization for increased isoprenoid production”, Applied and Environmental Microbiology, 74(10):3229-3241. [cited by applicant]
Merlin et al. (2003) “Why is carbonic anhydrase essential to [cited by applicant]